Tag Archives: Yi Chen
Co-Diagnostics Inc (CODX) Gets a Buy Rating from H.C. Wainwright
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Co-Diagnostics Inc (CODX – Research Report), with a price target of $2. The company’s shares closed last Monday at $1.12, close to its 52-week low
Analysts Offer Insights on Healthcare Companies: Bio-Path Holdings (NASDAQ: BPTH) and Fibrocell Science Inc (NASDAQ: FCSC)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Bio-Path Holdings (BPTH – Research Report) and Fibrocell Science Inc (FCSC – Research Report) with bullish sentiments. Bio-Path Holdings (BPTH) H.C. Wainwright
Analysts’ Top Healthcare Picks: Oragenics Inc (OGEN), Iovance Biotherapeutics Inc (IOVA)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oragenics Inc (OGEN – Research Report), Iovance Biotherapeutics Inc (IOVA – Research Report) and Arcturus Therapeutics Ltd (ARCT – Research Report) with
AzurRx BioPharma Inc (AZRX) Gets a Buy Rating from H.C. Wainwright
H.C. Wainwright analyst Yi Chen reiterated a Buy rating on AzurRx BioPharma Inc (AZRX – Research Report) today and set a price target of $6. The company’s shares closed last Monday at $0.97, close to its 52-week low of $0.86.
H.C. Wainwright Reiterates a Hold Rating on Aerpio Pharmaceuticals Inc (ARPO)
H.C. Wainwright analyst Yi Chen reiterated a Hold rating on Aerpio Pharmaceuticals Inc (ARPO – Research Report) today and set a price target of $1. The company’s shares closed yesterday at $0.69, close to its 52-week low of $0.65. Chen
H.C. Wainwright Sticks to Its Buy Rating for Veru Inc (VERU)
In a report released today, Yi Chen from H.C. Wainwright reiterated a Buy rating on Veru Inc (VERU – Research Report), with a price target of $4.50. The company’s shares closed yesterday at $2.12. Chen said: “Our price target is
